In an attempt to elucidate drivers of immune exclusion, we initially evaluated PD-L1/2 expression in primary and secondary HCC and found significant heterogeneity in expression, with evidence of more substantial discordance for PD-L1 tumoural immunolabelling. Here, CD274 is linked to hepatocellular carcinoma.